ArticleEpilepsy & behavior : E&B2006
Nonepileptic seizures treatment workshop summary.
Article in Epilepsy & behavior : E&B, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Treatment for Psychogenic Nonepileptic Seizures: A Pilot, 12 Week, Prospective, Randomized, Placebo-controlled, Double-blind, Clinical Trial of Sertraline in the Treatment of Comorbid Psychiatric Disorders in NES
Medication and Psychotherapy Treatment Trial for Psychogenic Nonepileptic Seizures
Evaluation d'un Dispositif de Suivi téléphonique Sur la Qualité de Vie Dans Les Crises Psychogènes Non Epileptiques.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children.PLoS medicine · 2008Pooled it
- Cognitive-behavioural therapy compared with standardised medical care for adults with dissociative non-epileptic seizures: the CODES RCT.Health technology assessment (Winchester, England) · 2021Trial
- Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures.Neurology · 2010Trial
- Functional movement disorder and functional seizures: What have we learned from different subtypes of functional neurological disorders?Epilepsy & behavior reports · 2022Review
- Psychogenic Nonepileptic Seizures (PNES) classification: still "time for progress".Arquivos de neuro-psiquiatria · 2021Article
- Treatment of psychogenic nonepileptic seizures: updated review and findings from a mindfulness-based intervention case series.Clinical EEG and neuroscience · 2015Review
- Closing the Major Gap in PNES Research: Finding a Home for a Borderland Disorder.Epilepsy currents · 2014Article
- Recent developments in our understanding of the semiology and treatment of psychogenic nonepileptic seizures.Current neurology and neuroscience reports · 2012Review
- Psychogenic nonepileptic seizures: a treatment review. What have we learned since the beginning of the millennium?Neuropsychiatric disease and treatment · 2012Article
- Interrater reliability of EEG-video monitoring.Neurology · 2009Article
- Psychogenic nonepileptic seizures.Neuropsychology review · 2007Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
In May 2005, an international, interdisciplinary group of researchers gathered in Bethesda, MD, USA, for a workshop to discuss the development of treatments for patients with nonepileptic seizures (NES). Specific subgroup topics that were covered included: pediatric NES; presenting the diagnosis of NES, outcome measures for NES trials; classification of NES subtypes; and pharmacological treatment approaches and psychotherapies. The intent was to develop specific research strategies that can be expanded to involve a large segment of the epilepsy and psychiatric treatment communities. Various projects have resulted from the workshop, including the initial development of a prospective randomized clinical trial for NES.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.